Related Experiment Video
Updated: May 6, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.5K
Sipuleucel-T: immunotherapy for advanced prostate cancer
Brian M Olson1, Douglas G McNeel
1University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
Open Access Journal of Urology
|November 8, 2013
Summary
Sipuleucel-T offers a new immunotherapy option for advanced prostate cancer, providing benefits without chemotherapy side effects. This active immunotherapy uses a patient's immune cells to target cancer cells.
Area of Science:
- Oncology
- Immunotherapy
Background:
- Prostate cancer is a leading cause of cancer death in American men.
- Metastatic, castrate-resistant prostate cancer treatments often involve chemotherapy with significant side effects.
- Sipuleucel-T represents a novel treatment approach for advanced prostate cancer.
Purpose of the Study:
- To review the development and implementation of sipuleucel-T for prostate cancer.
- To discuss the management of advanced prostate cancer and the role of sipuleucel-T.
- To explore future research directions for sipuleucel-T and other advanced prostate cancer therapies.
Main Methods:
- Review of scientific literature on sipuleucel-T development and clinical trials.
- Analysis of sipuleucel-T's mechanism of action as an active immunotherapy.
- Discussion of clinical management strategies for advanced prostate cancer.
Main Results:
- Sipuleucel-T is an antigen-presenting cell-based immunotherapy.
- It utilizes a patient's own immune cells to activate an immune response against tumor cells.
- Sipuleucel-T has demonstrated clinical benefit in advanced prostate cancer patients without chemotherapy-associated side effects.
Conclusions:
- Sipuleucel-T provides an alternative treatment option for advanced prostate cancer.
- Its approval may alter the clinical management of prostate cancer.
- Ongoing research is exploring sipuleucel-T's full potential and other therapeutic avenues.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K